Hypoxia Combined With Substance P Pretreatment of ADSC-Exos Promotes Recruitment and Differentiation of EPCs by Activating YAP/TEAD3 to Treat Diabetic Foot Ulcer.
Diabetic foot ulcers are a serious complication of diabetes that can lead to amputation, and current treatments often fail because the body's natural repair system is impaired. This study explored a new combination therapy using exosomes—tiny particles released by stem cells that carry healing signals—that were first exposed to low oxygen (hypoxia) and a signaling molecule called substance P. The researchers wanted to see if this pre-treated exosome mixture could better attract and mature endothelial progenitor cells (EPCs), which are cells that help build new blood vessels. In laboratory experiments and animal models, the treatment activated a cellular pathway called YAP/TEAD3, which improved the recruitment and specialization of EPCs. The results showed significantly faster wound healing and increased blood vessel formation compared to untreated controls, though exact percentages were not provided in the abstract. This approach could offer a new way to treat diabetic foot ulcers by enhancing the body's own repair mechanisms. However, this is still early-stage research, and human clinical trials are needed before it becomes available to patients.
Key takeaways
- The study uses exosomes from fat-derived stem cells, pre-treated with low oxygen and substance P, to enhance healing.
- This combination activated the YAP/TEAD3 pathway, which helped recruit and mature blood-vessel-forming cells.
- In animal models, the treatment led to faster wound closure and more new blood vessels compared to controls.
- If proven in humans, this could reduce amputation risk for diabetic foot ulcers, but human trials are still needed.
- Patients should ask their doctor about the status of exosome-based therapies and whether they are part of clinical trials.
- This research is not yet a routine treatment; it remains experimental and unavailable in standard care.
Read the full paper / source →
This content summarizes published medical research for educational purposes only. It does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making treatment decisions.
Free consultation
Could this treatment help you?
Our DFU specialists review every inquiry personally. Tell us about your situation — response within 48 hours, no commitment required.
This website provides medical-information science popularization only. It does NOT provide online diagnosis, prescriptions, or medical advice. Consult a licensed physician for any medical decision.
Editor's note
Think of your body's healing system as a river that's been dammed up by diabetes—this technique uses tiny messengers from stem cells to reopen those channels and let repair cells flow to the wound. For someone told their ulcer won't heal or amputation is the only option, this research offers a glimmer of hope: it shows that we can boost the body's own blood-vessel-building cells to speed healing, potentially saving limbs. However, this is still experimental—it's not routinely performed at China's specialist DFU centres yet. If you're considering travel to China, you can ask about clinical trials or innovative therapies, but be aware that proven standard treatments like debridement, offloading, and infection control remain the foundation of care.